Skip to content

a Flexible Wound Dressing for the Management of Genital Skin Conditions

Post-marketing Surveillance of a Flexible Wound Dressing for the Management of Genital Skin Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05396261
Enrollment
54
Registered
2022-05-31
Start date
2018-01-31
Completion date
2022-02-01
Last updated
2022-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic Vaginitis, Lichen Planus, Lichen Sclerosus, Menopause Related Conditions, Vaginitis

Brief summary

The objective of the study is to determine the efficacy of 7-0940 in the management of genital skin conditions in female patients

Interventions

Anecdotal evidence suggests that genital conditions in women associated with vaginal atrophy improve with the use of film-forming silicone dressings.

Sponsors

Stratpharma AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Able to provide informed consent * Diagnosed genital skin condition

Exclusion criteria

* Unable to give informed consent * Patient unable to apply topical device * Allergy or intolerance to ingredients or excipients of the formulation of studied products

Design outcomes

Primary

MeasureTime frameDescription
gynaecological skin conditionDuration of the therapy will be according to physician's clinical practice. The average is 3 visits over a period of 3 to 6 monthsLikert scales to measure: * Dryness * Tissue thinning * Erosion/Ulcers * Fissures * Erythema * Scarring/adhesion * Contact bleeding * Bloodblisters * Greyish film * White lacy streaks

Secondary

MeasureTime frameDescription
patient symptomsDuration of the therapy will be according to physician's clinical practice. The average is 3 visits over a period of 3 to 6 monthsLikert scales to measure: * Pruritus/itchiness * Tender/sore * Swelling * Dryness * Burning of skin * Dyspareunia * Stinging with urination/clothes * Defecating pain/burning

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026